Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA::GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.

  • deranger@lemmy.world
    link
    fedilink
    English
    arrow-up
    2
    arrow-down
    1
    ·
    edit-2
    1 year ago

    You don’t need 23&Me to do sketchy stuff for this to happen. They’ll just get your DNA from another blood test. They could simply provide a sizable discount to those who enroll and make the premium for “non genetic” insurance rather high in comparison.

    It’s one of the most stable physical data formats. It’s not hard to get someone’s DNA, nor is it hard to analyze these days. You also don’t need DNA to discriminate; they can just find parallel traits and use those.

    I dunno, none of this worries me that much. DNA is not that special in my mind. I leave it everywhere I go. It’s not private data - most people just don’t know how to read it.